Risk factor management of type 2 diabetic patients in primary care in the Scandinavian countries between 2003 and 2015-Reference-Cited by-同舟云学术

Risk factor management of type 2 diabetic patients in primary care in the Scandinavian countries between 2003 and 2015

Published:2021-04 Issue:2 Volume:15 Page:262-268
ISSN:1751-9918
Container-title:Primary Care Diabetes
language:en
Short-container-title:Primary Care Diabetes

Author:

Knudsen Søren Tang^ORCID,Bodegård Johan,Birkeland Kåre I.,Furuseth Kristian,Thuresson Marcus,Lindh Anders,Nilsson Peter M.,Alvarsson Michael,Jørgensen Marit Eika,Søndergaard Jens^ORCID,Persson Frederik^ORCID

Funder

Boehringer Ingelheim

Novartis

Novo Nordisk

Sanofi

Amgen

AstraZeneca

Meso Scale Diagnostics

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine,Family Practice

Reference20 articles.

1. 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Buse;Diabetologia,2020

2. Automated data extraction—a feasible way to construct patient registers of primary care utilization;Martinell;Ups J. Med. Sci.,2012

3. Introduction to the Danish Data Protection Agency Copenhagen;A. TDDP,2011

4. Data for research Copenhagen, Denmark;Denmark,2018

5. Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care;Rungby;Cardiovasc. Endocrinol.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The development of type 2 diabetes management in people with severe mental illness in the Capital Region of Denmark from 2001 to 2015;Acta Psychiatrica Scandinavica;2024-01-06

2. Inequalities in healthcare utilisation among adults with type 2 diabetes;Diabetes Research and Clinical Practice;2023-11

3. Guideline-level monitoring, biomarker levels and pharmacological treatment in migrants and native Danes with type 2 diabetes: Population-wide analyses;PLOS Global Public Health;2023-10-18

4. Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes;Diabetes and Vascular Disease Research;2023-05

5. Biochemical profiling, pharmacological management and clinical outcomes in type 2 diabetes in Danish primary care from 2001 to 2015;Primary Care Diabetes;2022-12